Who owns the CORETERRA THERAPEUTICS trademark?

The CORETERRA THERAPEUTICS trademark is owned by Coreterra Therapeutics, Inc..

What is the serial number for CORETERRA THERAPEUTICS?

The USPTO serial number for CORETERRA THERAPEUTICS is 99435527.

What is the registration number for CORETERRA THERAPEUTICS?

CORETERRA THERAPEUTICS is registered under USPTO registration number 0.

COR

USPTO Trademark Record

PENDING

CORETERRA THERAPEUTICS

Q: What class is the CORETERRA THERAPEUTICS trademark registered in?

The CORETERRA THERAPEUTICS trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 99435527·Reg 0·Filed Oct 09, 2025

Owner Coreterra Therapeutics, Inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CORETERRA THERAPEUTICS (Serial No. 99435527), Registration No. 0, is a pending US trademark filed on Oct 09, 2025 by Coreterra Therapeutics, Inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

Statement of Use due: November 19, 202624 days remaining

Mark Intelligence

CORETERRA THERAPEUTICS (Reg. #0) is a pending US trademark that was filed in 2025 and is currently under USPTO examination. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Oct 09, 2025

SERIAL

99435527

REG#

Owner

Applicant

Coreterra Therapeutics, Inc.

Entity

Corporation

State

Address

365 West Passaic Street, Suite 490, Rochelle Park, NJ, 07662

Country

Attorney

NameLynn E. Rzonca

Law firm

Lynn E. Rzonca Ballard Spahr LLP

Docket

00451404

Address

1735 Market Street, 51st Floor, Philadelphia, PA 19103, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusPENDING

Filing DateOct 09, 2025

Serial Number99435527

Registration No.0

Status DateMay 19, 2026

Published for OppositionMar 24, 2026

Mark TypeStandard characters

Attorney Docket00451404

Status DescriptionLive and pending, notice of allowance issued

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

13 events

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

May 19, 2026

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Mar 24, 2026

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Mar 24, 2026

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Mar 18, 2026

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

EXAMINERS AMENDMENT -WRITTEN

Mar 02, 2026

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 02, 2026

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 02, 2026

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 02, 2026

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 02, 2026

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Feb 27, 2026

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 11, 2026

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Oct 09, 2025

NEW APPLICATION ENTERED

APPLICATION FILING RECEIPT MAILED

Oct 09, 2025

APPLICATION FILING RECEIPT MAILED

CORETERRA THERAPEUTICS

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Coreterra Therapeutics, Inc.

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Lynn E. Rzonca

Resources

Company